[177Lu]-Catalase

N/A

Report date: 2025/11/28 15:16:20

Base Information

Drug Name[177Lu]-Catalase

Drug Alias NameLutetium [177Lu]-Catalase[Lu-177]-Catalase

ClassificationRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs > EnzymeRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionIonising radiation emitters

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBeijing Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer Hospital

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A